LYZ and neurosarcoidosis: In accordance with previous data (9, 10, 42, 53, 54), we confirm the low sensitivity of serum analysis except for lysozyme levels which were increased in almost 80% of our cohort, while it was reported abnormal in only half of patients with neurosarcoidosis in the literature (42).